Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis

Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis

Abstract Background Polypharmacy, often defined as the concomitant use of ≥ 5 medications, has been identified as a significant global public health threat. Aging and multimorbidity are key drivers of polypharmacy and have been linked to a broad range of adverse health outcomes and mortality. Patien...

Full description

Bibliographic Details
Main Authors: Ikechi G. Okpechi, Mohammed M. Tinwala, Shezel Muneer, Deenaz Zaidi, Feng Ye, Laura N. Hamonic, Maryam Khan, Naima Sultana, Scott Brimble, Allan Grill, Scott Klarenbach, Cliff Lindeman, Amber Molnar, Dorothea Nitsch, Paul Ronksley, Soroush Shojai, Boglarka Soos, Navdeep Tangri, Stephanie Thompson, Delphine Tuot, Neil Drummond, Dee Mangin, Aminu K. Bello
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Systematic Reviews
Subjects:
CKD
Polypharmacy
Elderly
Multimorbidity
Adverse effects
Prescriptions
Online Access:https://doi.org/10.1186/s13643-021-01752-z

Internet

https://doi.org/10.1186/s13643-021-01752-z

Similar Items